Anaplastic large cell lymphoma epidemiology and demographics
|
Anaplastic large cell lymphoma Microchapters |
|
Differentiating Anaplastic large cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anaplastic large cell lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Anaplastic large cell lymphoma epidemiology and demographics |
|
FDA on Anaplastic large cell lymphoma epidemiology and demographics |
|
CDC on Anaplastic large cell lymphoma epidemiology and demographics |
|
Anaplastic large cell lymphoma epidemiology and demographics in the news |
|
Blogs on Anaplastic large cell lymphoma epidemiology and demographics |
|
Directions to Hospitals Treating Anaplastic large cell lymphoma |
|
Risk calculators and risk factors for Anaplastic large cell lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Anaplastic large cell lymphoma is a common disease that tends to affect children or young adults. Males are more commonly affected with anaplastic large cell lymphoma than females.[1]
Epidemiology and Demographics
Age
- Patients of all age groups may develop anapastic large cell lymphoma [1]
- Anaplastic large cell lymphoma is a common disease that tends to affect children or young adults
- ALK-positive anaplastic large cell lymphoma usually affects younger individuals (between 10 and 29 years)[2]
- ALK-negative anaplastic large cell lymphoma usually affects older individuals (between 40-60 years)
Gender
- Males are more commonly affected with anaplastic large cell lymphoma than females[1]
References
- ↑ 1.0 1.1 1.2 Anaplastic large cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/anaplastic-large-cell-lymphoma/?region=on Accessed on October 7, 2015
- ↑ Stein H, Foss HD, Dürkop H, Marafioti T, Delsol G, Pulford K; et al. (2000). "CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features". Blood. 96 (12): 3681–95. PMID 11090048.